NL
NL · NL · NL-b26181d17052
RINVOQ 30 mg tabletten met verlengde afgifte
ATC L04AF03
Last synced from CBG-MEB (Netherlands) on
Identification
ManufacturerAbbVie Deutschland GmbH & Co. KG
CountryNL (NL)
ATC codeL04AF03
Dispensing—
ReimbursedNo
SourceCBG-MEB (Netherlands)
Last synced6/9/2026
Packs · 1
- cbg_meb_idEU/1/19/1404
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Tablet met verlengde afgifte",
"route": "Oraal gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/rinvoq-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Upadacitinib",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp127466",
"excipients": [
"CELLULOSE, MICROKRISTALLIJN (E 460(i))",
"HYPROMELLOSE 2208 (Release controlling polymer), K4M (E 464)",
"IJZEROXIDE ROOD (E 172)",
"MACROGOL 3350",
"MAGNESIUMSTEARAAT (E 470b)",
"MANNITOL (D-) (E 421)",
"POLYVINYLALCOHOL (E 1203)",
"SILICIUMDIOXIDE (E 551)",
"TALK (E 553b)",
"TITAANDIOXIDE (E 171)",
"WIJNSTEENZUUR, (L (+) Vorm) (E 334)"
],
"substances": [
"UPADACITINIB 0,5-WATER"
],
"leaflet_url": null,
"authorised_at": "2021/08/20",
"procedure_number": "EMEA/H/C/004760",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/19/1404",
"additional_monitoring": "N"
}Related drugs
Other records sharing ATC code L04AF03.
Access this data programmatically
Query RINVOQ 30 mg tabletten met verlengde afgifte and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.